Showing results (51-60 of 621) with videos related to
Sort By:
Pageof 63
The American Journal of Pathology|April 17, 2010
The impact of fingolimod (FTY720) in neuroimmunologic diseases: mechanisms beyond immunomodulationAiden Haghikia, Ralf GoldExperimental Neurology|February 27, 2014
Mode of action and clinical studies with fumarates in multiple sclerosisAnke Salmen, Ralf GoldNeurological Research and Practice|December 16, 2020
Severe pneumonia with formation of a pulmonary cavity associated with long-term rituximab therapy in multiple sclerosisCarolin Schwake, Ralf GoldExpert Opinion on Pharmacotherapy|November 13, 2013
Review of laquinimod and its therapeutic potential in multiple sclerosisJan Thöne, Ralf GoldNeurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 25, 2015
Present and Future Therapies in Neuromyelitis Optica Spectrum DisordersIngo Kleiter, Ralf GoldCurrent Opinion in Neurology|September 28, 2002
Animal models of immune-mediated neuropathiesMathias Mäurer, Ralf GoldJournal of Neurology|June 8, 2011
Progressive multifocal leukoencephalopathy and natalizumabKerstin Hellwig, Ralf GoldJournal of Neurology|January 9, 2004
Lessons from 10 years of interferon beta-1b (Betaferon/Betaseron) treatmentAntonios Bayas, Ralf GoldJournal of Neurology|May 16, 2007
Neuropsychological/-psychiatric deficits in immune-mediated neuropathiesAndrew Chan, Ralf GoldFrontiers in Immunology|August 8, 2025
Correction: The P2X7R-antagonist AFC-5128 ameliorates chronic experimental autoimmune encephalomyelitis in a preventive and therapeutic paradigmRobert Hoffrogge, Anna Karachunskaya, Neele Heitmann, et al.Pageof 63